Terns Pharmaceuticals
TERN
TERN
139 hedge funds and large institutions have $666M invested in Terns Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 128 → 139 (+11)
6.12% more ownership
Funds ownership: 95.16% → 101.28% (+6.1%)
5% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 42
Holders
139
Holding in Top 10
5
Calls
$5.47M
Puts
$380K
Top Buyers
| 1 | +$42.8M | |
| 2 | +$20M | |
| 3 | +$8.29M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.88M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$2.7M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$8.7M | |
| 3 | -$3.73M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.16M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.95M |
